Jeffrey R. Fineman BA, MD

Dr. Jeffrey Fineman is a pediatric critical care specialist, or intensivist, and the division chief of Critical Care. He also is an associate investigator of the Cardiovascular Research Institute. His research has led to new therapies for pulmonary hypertension, including a drug called inhaled nitric oxide, which was approved by the U.S. Food and Drug Administration. Fineman's research has focused on diseases related to pulmonary circulation. In particular, he has been interested in the pathophysiology of pulmonary hypertension and heads a laboratory, funded by the National Institutes of Health, for these investigations.

Fineman completed undergraduate training at the State University of New York, Binghamton, medical training at New York University and pediatric training at New York University's Bellevue Medical Center, where he served as pediatric chief resident. He completed a pediatric critical care fellowship at UCSF in 1988 and joined the staff of UCSF Benioff Children's Hospital in 1990.